446876-96-6

Basic information

• Product Name: 2-Butanone, 4-[[(4-methylphenyl)sulfonyl]oxy]-
• CAS NO: 446876-96-6
• Molecular Formula: C11H14O4S
• Molecular Weight: 242.296
• Mol File: 446876-96-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-Butanone, 4-[[(4-methylphenyl)sulfonyl]oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Butanone, 4-[[(4-methylphenyl)sulfonyl]oxy]-(446876-96-6)
• EPA Substance Registry System: 2-Butanone, 4-[[(4-methylphenyl)sulfonyl]oxy]-(446876-96-6)

Safety Data

• Hazardous Substances Data: 446876-96-6(Hazardous Substances Data)

Upstream product

• 590-90-9 1-Hydroxy-3-butanone 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 876370-60-4 methyl 3-hydroxy-3-methyl-5-tosyloxypentanone 
• 174666-19-4 4-(3-oxobutyl)benzoic acid ethyl ester 

Relevant articles and documents

Gold N-Heterocyclic Carbene Catalysts for the Hydrofluorination of Alkynes Using Hydrofluoric Acid: Reaction Scope, Mechanistic Studies and the Tracking of Elusive Intermediates

An efficient and chemoselective methodology deploying gold-N-heterocyclic carbene (NHC) complexes as catalysts in the hydrofluorination of terminal alkynes using aqueous HF has been developed. Mechanistic studies shed light on an in situ generated catalyst, formed by the reaction of Br?nsted basic gold pre-catalysts with HF in water, which exhibits the highest reactivity and chemoselectivity. The catalytic system has a wide alkyl substituted-substrate scope, and stoichiometric as well as catalytic reactions with tailor-designed gold pre-catalysts enable the identification of various gold species involved along the catalytic cycle. Computational studies aid in understanding the chemoselectivity observed through examination of key mechanistic steps for phosphine- and NHC-coordinated gold species bearing the triflate counterion and the elusive key complex bearing a bifluoride counterion.

Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase

Mevalonate 5-diphosphate decarboxylase plays an important role in regulating cholesterol biosynthesis, which was studied through incubation with various synthetic substrate analogs and characterization of mutated enzymes. The results are potentially useful for further developing inhibitors that block the mevalonate pathway which is a drug target for treating cardiovascular disease and cancer.